At the time of writing, Lifecore Biomedical Inc [LFCR] stock is trading at $8.18, up 1.11%. An important factor to consider is whether the stock is rising or falling in short-term value. The LFCR shares have gain 1.49% over the last week, with a monthly amount glided 4.60%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On September 05, 2024, Craig Hallum initiated with a Buy rating and assigned a price target of $8 on the stock. Barrington Research downgraded its rating to a Mkt Perform. Stephens downgraded its rating to a Equal-Weight and reduced its price target to $2 on March 20, 2023.
For the past year, the stock price of Lifecore Biomedical Inc fluctuated between $4.76 and $8.85. Currently, Wall Street analysts expect the stock to reach $6.5 within the next 12 months. Lifecore Biomedical Inc [NASDAQ: LFCR] shares were valued at $8.18 at the most recent close of the market. An investor can expect a potential drop of -20.54% based on the average LFCR price forecast.
Analyzing the LFCR fundamentals
According to Lifecore Biomedical Inc [NASDAQ:LFCR], the company’s sales were 128.87M for trailing twelve months, which represents an 25.92% jump. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.24%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -2.33 and Total Capital is -0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.74.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.03 points at the first support level, and at 7.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.28, and for the 2nd resistance point, it is at 8.39.
Ratios To Look Out For
It is important to note that Lifecore Biomedical Inc [NASDAQ:LFCR] has a current ratio of 2.80. On the other hand, the Quick Ratio is 1.67, and the Cash Ratio is 0.63. Considering the valuation of this stock, the price to sales ratio is 2.38.
Transactions by insiders
Recent insider trading involved English Aron R., 10% Owner, that happened on May 27 ’25 when 1.14 million shares were sold. 10% Owner, English Aron R. completed a deal on May 28 ’25 to sell 0.15 million shares. Meanwhile, 10% Owner English Aron R. sold 96137.0 shares on May 23 ’25.
